Coagulation abnormalities in acute lung injury and sepsis

Am J Respir Cell Mol Biol. 2000 Apr;22(4):401-4. doi: 10.1165/ajrcmb.22.4.f184.
No abstract available

Publication types

  • Comment

MeSH terms

  • Acute Disease
  • Animals
  • Antithrombin III / therapeutic use
  • Blood Coagulation Disorders / etiology*
  • Complement Activation
  • Cytokines / toxicity
  • Disseminated Intravascular Coagulation / drug therapy
  • Disseminated Intravascular Coagulation / etiology
  • Endotoxemia / blood
  • Endotoxemia / complications
  • Fibrin / metabolism
  • Gene Expression Regulation
  • Hemorrhage / blood
  • Hemorrhage / classification
  • Humans
  • Lipoproteins / physiology
  • Lipoproteins / therapeutic use
  • Lung Injury*
  • Primates
  • Protein C / therapeutic use
  • Reactive Oxygen Species
  • Respiratory Distress Syndrome / blood*
  • Respiratory Distress Syndrome / complications
  • Sepsis / blood*
  • Sepsis / complications
  • Thromboplastin / biosynthesis
  • Thromboplastin / genetics
  • Thromboplastin / physiology
  • Transcription, Genetic
  • Tumor Necrosis Factor-alpha / adverse effects
  • Tumor Necrosis Factor-alpha / pharmacology
  • Tumor Necrosis Factor-alpha / physiology

Substances

  • Cytokines
  • Lipoproteins
  • Protein C
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • lipoprotein-associated coagulation inhibitor
  • Antithrombin III
  • Fibrin
  • Thromboplastin